Merck Canada announces a $4 million grant to support patient-centered care

PRESS RELEASEMerck Canada announced at the Sherbrooke International Life Sciences Summit that it is reinforcing its commitment to the Quebec life sciences research innovation sector by providing a $4 million grant to the Fonds de recherche du Québec – Santé (FRQS) for academic research. The FRQS grant will go towards supporting patient-oriented research conducted by the Strategy for Patient-Oriented Research (SPOR) initiative.

« The initiatives we support are a part of our approach to research and development (R&D) which is about building collaborative research relationships. In our view, private-public partnerships provide a fertile environment for innovation to grow and lead to new and efficient ways of caring for patients, » said Dr. Thomas R. Cannell, President and Managing Director, Merck Canada Inc.

« The investment that Merck Canada announced today is excellent news for research in the health sector and serves as a testament to a partnership built between this private firm and public research institutions in Quebec. In addition, this investment is in line with an important imperative for the Quebec Government being early stage research, » said Quebec Minister of Health and Social Services, Dr. Réjean Hébert.

Developing a strong infrastructure for research

« The Fonds de recherche du Québec-Santé is grateful for this grant that will go towards supporting patient-oriented care, » said Dr. Renaldo Battista, Scientific Director of the FRQS. « At the core of everything we do is the patient, our patient focused research is about ensuring that the right patient receives the right intervention at the right time. »

This announcement marks the latest contribution by Merck towards its commitment to inject $100 million over five years in biopharmaceutical R&D in Quebec. Today’s announcement brings Merck’s total contributions to date to approximately $68 million.

Note: All amounts expressed in this press release are in Canadian dollars unless otherwise noted.

About Merck
Today’s Merck is a global healthcare leader working to help the world be well.  Merck is known as MSD outside the United States and Canada. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information about our operations in Canada, visit

About FQRS
The FRQS (Fonds de recherche du Québec – Santé) is a non-profit funding agency reporting to the Minister of the Enseignement Supérieur, de la Recherche, de la Science et de la Technologie (MESRST). Its mandate is to implement government strategy with respect to human health research as presented in the Québec Research and Innovation Strategy. The FRQS plays a leading role in planning and coordinating the development of health research in Québec. For more information about FRQS, please visit